Publication & Citation Trends
Publications
53 total
Phase 1b study of a small molecule antagonist of human chemokine (C-C motif) receptor 2 (PF-04136309) in combination with nab-paclitaxel/gemcitabine in first-line treatment of metastatic pancreatic ductal adenocarcinoma PDF
Cited by 178
OpenAlex
Preliminary Efficacy of the Anti-Insulin–Like Growth Factor Type 1 Receptor Antibody Figitumumab in Patients With Refractory Ewing Sarcoma PDF
Cited by 211
OpenAlex
Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study PDF
Cited by 338
OpenAlex
Safety, tolerability, and pharmacokinetics of the anti-IGF-1R monoclonal antibody figitumumab in patients with refractory adrenocortical carcinoma PDF
Cited by 191
OpenAlex
Phase I, Pharmacokinetic and Pharmacodynamic Study of the Anti–Insulinlike Growth Factor Type 1 Receptor Monoclonal Antibody CP-751,871 in Patients With Multiple Myeloma PDF
Cited by 160
OpenAlex
Research Topics
Biosimilars and Bioanalytical Methods
(18)
HER2/EGFR in Cancer Research
(12)
Monoclonal and Polyclonal Antibodies Research
(12)
Statistical Methods in Clinical Trials
(11)
Growth Hormone and Insulin-like Growth Factors
(8)
Affiliations
St. Jude Children's Research Hospital
Mayo Clinic
University of Tennessee Health Science Center
Pfizer (United States)
Moffitt Cancer Center